Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Report

China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Market Research Report 2023-2029

  • POSTDATE：Sep 09, 2023
  • PAGES：160
  • REPORT CODE：GMM1784701
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Contract Research Organization (CRO) and CDMO for Pharmaceutical industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • PRA HEALTH SCIENCES INC

    • NextPharma

    • ICON PLC

    • EPS INTERNATIONAL

    • IQVIA HOLDINGS INC

    • Syneos Health Inc

    • PAREXEL International Corporation

    • GenScript Biotech Corporation

    • Medpace Holdings Inc

    • SGS SA

    • Eurofins Scientific

    • Envigo

    • EVOTEC AG

    • WuXi AppTec

    By Type:

    • Transient Transfection CRO Service

    • Others

    • Protein Production and Purification Service

    • Antibody Production and Development Service

    • Molecular Biology Service

    By Application:

    • Pharmaceutical and Biopharmaceutical Companies

    • Research Institutes

    • Others

    • Academic Institutes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Overview 2018-2029

    • 1.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Development Overview

    • 1.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Development History

    • 1.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Market Size (2018-2029)

    • 1.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Type from Production Side

      • 1.4.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Transient Transfection CRO Service (2018-2029)

      • 1.4.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Protein Production and Purification Service (2018-2029)

      • 1.4.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Antibody Production and Development Service (2018-2029)

      • 1.4.5 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Molecular Biology Service (2018-2029)

    • 1.5 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Application from Consumption End

      • 1.5.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Pharmaceutical and Biopharmaceutical Companies (2018-2029)

      • 1.5.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Research Institutes (2018-2029)

      • 1.5.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Academic Institutes (2018-2029)

    • 1.6 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Region

      • 1.6.1 North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    Chapter 2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Status and Competition Analysis in 2023

      • 2.2.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Development

    Chapter 3 Contract Research Organization (CRO) and CDMO for PharmaceuticalIndustry Chain Analysis

    • 3.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Chain

    • 3.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Contract Research Organization (CRO) and CDMO for Pharmaceutical Market

    • 3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Contract Research Organization (CRO) and CDMO for Pharmaceutical Market

    Chapter 4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 4.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Production Volume and Growth Rate from Production Side

    • 4.5 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate, by Type

      • 4.5.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Transient Transfection CRO Service

      • 4.5.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Others

      • 4.5.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Protein Production and Purification Service

      • 4.5.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Antibody Production and Development Service

      • 4.5.5 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Molecular Biology Service

    Chapter 5 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Market Size and Growth Rate from Consumption End

    • 5.5 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate, by Application

      • 5.5.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Pharmaceutical and Biopharmaceutical Companies

      • 5.5.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Research Institutes

      • 5.5.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Others

      • 5.5.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Academic Institutes

    Chapter 6 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Region

    • 6.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Production Value, by Region

    • 6.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume and Sales Value, by Region

    Chapter 7 North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 7.1 North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 7.2 North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 8 Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 8.1 Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 8.2 Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 9 South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 9.1 South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 9.2 South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 10 East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 10.1 East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 10.2 East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 11 Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 11.1 Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 11.2 Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 12 Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 12.1 Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 12.2 Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 13 Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis

    • 13.1 Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

    • 13.2 Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

    Chapter 14 Company Profiles

      • 14.1 PRA HEALTH SCIENCES INC

        • 14.1.1 PRA HEALTH SCIENCES INC Company Profile

        • 14.1.2 PRA HEALTH SCIENCES INC Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 NextPharma

        • 14.2.1 NextPharma Company Profile

        • 14.2.2 NextPharma Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 ICON PLC

        • 14.3.1 ICON PLC Company Profile

        • 14.3.2 ICON PLC Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 EPS INTERNATIONAL

        • 14.4.1 EPS INTERNATIONAL Company Profile

        • 14.4.2 EPS INTERNATIONAL Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 IQVIA HOLDINGS INC

        • 14.5.1 IQVIA HOLDINGS INC Company Profile

        • 14.5.2 IQVIA HOLDINGS INC Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Syneos Health Inc

        • 14.6.1 Syneos Health Inc Company Profile

        • 14.6.2 Syneos Health Inc Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 PAREXEL International Corporation

        • 14.7.1 PAREXEL International Corporation Company Profile

        • 14.7.2 PAREXEL International Corporation Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 GenScript Biotech Corporation

        • 14.8.1 GenScript Biotech Corporation Company Profile

        • 14.8.2 GenScript Biotech Corporation Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Medpace Holdings Inc

        • 14.9.1 Medpace Holdings Inc Company Profile

        • 14.9.2 Medpace Holdings Inc Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 SGS SA

        • 14.10.1 SGS SA Company Profile

        • 14.10.2 SGS SA Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Eurofins Scientific

        • 14.11.1 Eurofins Scientific Company Profile

        • 14.11.2 Eurofins Scientific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Envigo

        • 14.12.1 Envigo Company Profile

        • 14.12.2 Envigo Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 EVOTEC AG

        • 14.13.1 EVOTEC AG Company Profile

        • 14.13.2 EVOTEC AG Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 WuXi AppTec

        • 14.14.1 WuXi AppTec Company Profile

        • 14.14.2 WuXi AppTec Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Research Conclusions

    • 15.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Market Size (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Transient Transfection CRO Service (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Protein Production and Purification Service (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Antibody Production and Development Service (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume, Production Value and Growth Rate of Molecular Biology Service (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Pharmaceutical and Biopharmaceutical Companies (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Research Institutes (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume, Sales Value and Growth Rate of Academic Institutes (2018-2029)

    • Figure North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2018-2029

    • Figure Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Type in 2018

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Type in 2023

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Transient Transfection CRO Service (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Protein Production and Purification Service (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Antibody Production and Development Service (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume and Growth Rate of Molecular Biology Service (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Application in 2018

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Application in 2023

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Market Size and Growth Rate from Consumption End

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Pharmaceutical and Biopharmaceutical Companies (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Research Institutes (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Others (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Academic Institutes (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Region (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Value by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Value Share by Region (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Value Share by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Region (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2018-2023)

    • Table China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value Share by Region (2018-2023)

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value Share by Region (2018-2023)

    • Table North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure North China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure Central China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure South China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure East China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume by Type (2018-2023)

    • Table Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Figure Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Volume Share by Type (2018-2023)

    • Table Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume by Application (2018-2023)

    • Table Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Volume Share by Application (2018-2023)

    • Table PRA HEALTH SCIENCES INC Company Profile

    • Table PRA HEALTH SCIENCES INC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table NextPharma Company Profile

    • Table NextPharma Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table ICON PLC Company Profile

    • Table ICON PLC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table EPS INTERNATIONAL Company Profile

    • Table EPS INTERNATIONAL Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table IQVIA HOLDINGS INC Company Profile

    • Table IQVIA HOLDINGS INC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table Syneos Health Inc Company Profile

    • Table Syneos Health Inc Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table PAREXEL International Corporation Company Profile

    • Table PAREXEL International Corporation Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table GenScript Biotech Corporation Company Profile

    • Table GenScript Biotech Corporation Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table Medpace Holdings Inc Company Profile

    • Table Medpace Holdings Inc Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table SGS SA Company Profile

    • Table SGS SA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table Eurofins Scientific Company Profile

    • Table Eurofins Scientific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table Envigo Company Profile

    • Table Envigo Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table EVOTEC AG Company Profile

    • Table EVOTEC AG Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)

    • Table WuXi AppTec Company Profile

    • Table WuXi AppTec Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US